BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27981384)

  • 21. The development and validation of automated machine learning models for predicting lymph node metastasis in Siewert type II T1 adenocarcinoma of the esophagogastric junction.
    Lu C; Liu L; Yin M; Lin J; Zhu S; Gao J; Qu S; Xu G; Liu L; Zhu J; Xu C
    Front Med (Lausanne); 2024; 11():1266278. PubMed ID: 38633305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-Incision laparoscopic intragastric surgery for gastric submucosal tumors located near the esophagogastric junction: A technical note.
    Zeng CY; Liu XY; Liu TY; Li S
    Asian J Surg; 2024 May; 47(5):2484-2485. PubMed ID: 38296685
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical significance of esophageal invasion length for the prediction of mediastinal lymph node metastasis in Siewert type II adenocarcinoma: A retrospective single-institution study.
    Koyanagi K; Kato F; Kanamori J; Daiko H; Ozawa S; Tachimori Y
    Ann Gastroenterol Surg; 2018 May; 2(3):187-196. PubMed ID: 29863189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nonrandomized controlled trial: long-term outcomes of LATG/LAPG for cStage I gastric cancer: Japan Clinical Oncology Group Study JCOG1401.
    Kunisaki C; Katai H; Sakuramoto S; Mizusawa J; Katayama H; Kadoya S; Yamada T; Kinoshita T; Yoshikawa T; Terashima M;
    Gastric Cancer; 2024 Jan; 27(1):164-175. PubMed ID: 37875696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative superior anastomotic leakage classification and treatment strategy for postoperative esophagogastric junction cancer.
    Zhang J; Li C; Ma P; Cao Y; Włodarczyk J; Ibrahim M; Liu C; Li S; Zhang X; Han G; Zhao Y
    J Gastrointest Oncol; 2024 Feb; 15(1):12-21. PubMed ID: 38482214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Landscape of Adenocarcinomas Across the Gastroesophageal Junction: Moving on from the Siewert Classification.
    Nakauchi M; Walch HS; Nussenzweig S; Carr R; Vos E; Berger MF; Schultz N; Janjigian Y; Wu A; Tang L; Shah P; Jones DR; Coit D; Strong VE; Molena D; Sihag S
    Ann Surg; 2024 Jun; ():. PubMed ID: 38841851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of surgery for gastric cancer with distant metastases: a retrospective study from the SEER database.
    Chen J; Kong Y; Weng S; Dong C; Zhu L; Yang Z; Zhong J; Yuan Y
    Oncotarget; 2017 Jan; 8(3):4342-4351. PubMed ID: 28008147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?
    Chan DY; Syn NL; Yap R; Phua JN; Soh TI; Chee CE; Nga ME; Shabbir A; So JB; Yong WP
    J Gastrointest Surg; 2017 Mar; 21(3):425-433. PubMed ID: 27981493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
    Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term oncological outcomes of laparoscopic versus open transhiatal resection for patients with Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kuwata T; Tokunaga M; Kaito A; Watanabe M; Tonouchi A; Sato R; Nagino M
    Surg Endosc; 2021 Jan; 35(1):340-348. PubMed ID: 32025923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transthoracic single-port-assisted laparoscopic gastrectomy versus laparoscopic transhiatal approach for Siewert type II adenocarcinoma of the esophagogastric junction: a single-center retrospective study.
    Li J; Xiong W; Ou H; Yang T; Jiang S; Huang H; Zheng Y; Luo L; Peng X; Wang W
    Surg Endosc; 2024 Apr; 38(4):1986-1994. PubMed ID: 38381159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimally invasive surgery for gastro-oesophageal junction adenocarcinoma: Current evidence and future perspectives.
    Bîrlă R; Hoara P; Achim F; Dinca V; Ciuc D; Constantinoiu S; Constantin A
    World J Gastrointest Oncol; 2023 Oct; 15(10):1675-1690. PubMed ID: 37969407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential updates 2021/2022: Perioperative and surgical treatments for gastric and esophagogastric junction cancer.
    Yanagimoto Y; Kurokawa Y; Doki Y
    Ann Gastroenterol Surg; 2023 Sep; 7(5):698-708. PubMed ID: 37663969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robotic versus open approach in total gastrectomy for gastric cancer: a comparative single-center study of perioperative outcomes.
    Salvador-Rosés H; Escartín A; Muriel P; Santamaría M; González M; Jara J; Vela F; Olsina JJ
    J Robot Surg; 2023 Aug; 17(4):1735-1741. PubMed ID: 37004708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic
    Li S; Ying X; Shan F; Jia Y; Li Z; Xue K; Miao R; Wang Y; Bu Z; Su X; Li Z; Ji J
    Chin J Cancer Res; 2022 Aug; 34(4):406-414. PubMed ID: 36199536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total laparoscopic versus laparoscopic-assisted transabdominal posterior mediastinal digestive tract reconstruction in the treatment of Siewert II adenocarcinoma of the esophagogastric junction: A retrospective study.
    Wang L; Chen X; Miao W; Ma Y; Ma X; Wang C; Cao X; Xu H; Wei J; Yan S
    Front Surg; 2022; 9():874857. PubMed ID: 36061040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic-assisted
    Song QY; Li XG; Zhang LY; Wu D; Li S; Zhang BL; Xu ZY; Wu RL; Guo X; Wang XX
    World J Gastrointest Surg; 2022 Apr; 14(4):304-314. PubMed ID: 35664362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current treatments and outlook in adenocarcinoma of the esophagogastric junction: a narrative review.
    Cao F; Hu C; Xu ZY; Zhang YQ; Huang L; Chen JH; Qin JJ; Cheng XD
    Ann Transl Med; 2022 Mar; 10(6):377. PubMed ID: 35433931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and efficacy of transthoracic single-port assisted laparoscopic esophagogastrectomy for Siewert type II adenocarcinoma of the esophagogastric junction.
    Luo S; Xu J; Xiong W; Li J; Luo L; Zheng Y; Zeng H; Liu Y; Yang L; Wu Z; Yang X; Wang W
    Ann Transl Med; 2021 Oct; 9(20):1540. PubMed ID: 34790746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-Term Clinical Efficacy of Neoadjuvant Chemotherapy Combined With Laparoscopic Gastrectomy for Locally Advanced Siewert Type II and III Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Propensity Score-Matched Study.
    Feng Q; Long D; Du MS; Wang XS; Li ZS; Zhao YL; Qian F; Wen Y; Yu PW; Shi Y
    Front Oncol; 2021; 11():690662. PubMed ID: 34660265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.